Srimathy Ramachandran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Srimathy Ramachandran has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Suma Mohan Saraswathi
Computational Biology lab, Bioinformatics Center, School of Chemical and Biotechnology, SASTRA Deemed to be University, Thanjavur, India
2 shared publications - Abhi V. Badiger
Ayurveda Biology and Holistic Nutrition, The University of Transdisciplinary Health Sciences and Technology (TDU), No.74/2, Jarakabande Kaval, Post: Attur, Via Yelahanka, Bengaluru, 560 106, Karnataka, India
1 shared publication - Anjana Thottappillil
Ayurveda Biology and Holistic Nutrition, The University of Transdisciplinary Health Sciences and Technology (TDU), No.74/2, Jarakabande Kaval, Post: Attur, Via Yelahanka, Bengaluru, 560 106, Karnataka, India
1 shared publication B Sruthi
1 shared publication- Chethala N. Vishnuprasad
Ayurveda Biology and Holistic Nutrition, The University of Transdisciplinary Health Sciences and Technology (TDU), No.74/2, Jarakabande Kaval Post: Attur, Via Yelahanka, Bengaluru – 560-064, Karnataka, India
1 shared publication K Deepak
1 shared publication
Latest Publications
- Open Access
- 9 July 2026
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 17 (4) , 101359
The systemic anti-diabetic effect of polyherbal formulation Varanadi Kashayam is mediated through GLP-1 secretion and DPP4 inhibition
- 9 July 2026
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 17 (4) , 101359
Open AccessThe systemic anti-diabetic effect of polyherbal formulation Varanadi Kashayam is mediated through GLP-1 secretion and DPP4 inhibition
- Open Access
Unveiling Meropenem Resistance and Co-Resistance Patterns in Klebsiella pneumoniae and Acinetobacter baumannii : A Global Genome Analysis Using ML/DL and Association Mining
Background: The increasing prevalence of meropenem-resistant gram-negative bacteria has significantly undermined its effectiveness and has increased treatment failure and mortality rates. The global availability of bacterial WGS data with antimicrobial resistance phenotypes enables large-scale genome analysis to explore resistance determinants. This study investigated the meropenem resistance mechanism in multidrug-resistant (MDR) Klebsiella pneumoniae (KP) and Acinetobacter baumannii (AB) isolates using advanced data analytics approaches. Methods: We analysed 2,411 KP and 375 AB isolates with meropenem-resistant and susceptible phenotypes from the BV-BRC database. AMR genes and mutations were identified from the isolates using the CARD database as a reference. Significant AMR genes and missense mutations, determined through chi-square tests, were subsequently used to train ML and DL models. The best-performing SVM model was used for sequential feature selection to identify key features. Additionally, association mining was conducted separately on the selected features and the antibiotics data. Results: Notable differences were observed in the proportions of genes contributing to the meropenem resistance mechanism categories between KP and AB, including carbapenemases (4% in KP, 23% in AB), antibiotic efflux (30%, 60%), target alteration (23%, 12%), and reduced permeability (18%, 3%). Mutation frequencies also vary, with antibiotic efflux (26%, 67%), target alteration (64%, 5%), and reduced permeability (7%, 15%). A total of 410 significant features in KP and 211 in AB were identified for model building. SVM-based feature selection pinpointed seven key features in KP and 10 in AB, resulting in 95% accuracy for both. Association mining revealed bla KPC-2 , bla KPC-3 , ble MBL , and aac(6’)-Ib9 as key factors in KP, and bla OXA-23 , Abau_gyrA_FLO|Ser81Leu, and Abau_OprD_IMP|Asn411Asp in AB associated with meropenem resistance. The observed prevalence of AAC genes and the gyrA mutation, along with insights from association mining, reveals the co-resistance of meropenem with aminoglycosides and fluoroquinolones, while oprD mutations imply potential shared resistance across antibiotics. Conclusion: The analysis of AMR genes and mutations based on resistance mechanisms revealed distinct differences in meropenem resistance between KP and AB. The ML/DL models and association mining approaches identified key resistance features and cross-antibiotic resistance insights. These findings deepen our understanding of meropenem resistance, enabling more precise and effective antimicrobial interventions.
Open AccessUnveiling Meropenem Resistance and Co-Resistance Patterns in Klebsiella pneumoniae and Acinetobacter baumannii : A Global Genome Analysis Using ML/DL and Association Mining
Background: The increasing prevalence of meropenem-resistant gram-negative bacteria has significantly undermined its effectiveness and has increased treatment failure and mortality rates. The global availability of bacterial WGS data with antimicrobial resistance phenotypes enables large-scale genome analysis to explore resistance determinants. This study investigated the meropenem resistance mechanism in multidrug-resistant (MDR) Klebsiella pneumoniae (KP) and Acinetobacter baumannii (AB) isolates using advanced data analytics approaches. Methods: We analysed 2,411 KP and 375 AB isolates with meropenem-resistant and susceptible phenotypes from the BV-BRC database. AMR genes and mutations were identified from the isolates using the CARD database as a reference. Significant AMR genes and missense mutations, determined through chi-square tests, were subsequently used to train ML and DL models. The best-performing SVM model was used for sequential feature selection to identify key features. Additionally, association mining was conducted separately on the selected features and the antibiotics data. Results: Notable differences were observed in the proportions of genes contributing to the meropenem resistance mechanism categories between KP and AB, including carbapenemases (4% in KP, 23% in AB), antibiotic efflux (30%, 60%), target alteration (23%, 12%), and reduced permeability (18%, 3%). Mutation frequencies also vary, with antibiotic efflux (26%, 67%), target alteration (64%, 5%), and reduced permeability (7%, 15%). A total of 410 significant features in KP and 211 in AB were identified for model building. SVM-based feature selection pinpointed seven key features in KP and 10 in AB, resulting in 95% accuracy for both. Association mining revealed bla KPC-2 , bla KPC-3 , ble MBL , and aac(6’)-Ib9 as key factors in KP, and bla OXA-23 , Abau_gyrA_FLO|Ser81Leu, and Abau_OprD_IMP|Asn411Asp in AB associated with meropenem resistance. The observed prevalence of AAC genes and the gyrA mutation, along with insights from association mining, reveals the co-resistance of meropenem with aminoglycosides and fluoroquinolones, while oprD mutations imply potential shared resistance across antibiotics. Conclusion: The analysis of AMR genes and mutations based on resistance mechanisms revealed distinct differences in meropenem resistance between KP and AB. The ML/DL models and association mining approaches identified key resistance features and cross-antibiotic resistance insights. These findings deepen our understanding of meropenem resistance, enabling more precise and effective antimicrobial interventions.